Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (24)
Ali Akgul, Christian Furlan Freguia, Massimo Maddaloni, Carol Hoffman, Alexandria Voigt, Cuong Q. Nguyen, Neil A. Fanger, Gary R. Fanger & David W. Pascual. (2023) Treatment with a Lactococcus lactis that chromosomally express E. coli cfaI mitigates salivary flow loss in a Sjögren’s syndrome-like disease. Scientific Reports 13:1.
Crossref
Crossref
Saba Fooladi, Navid Rabiee & Siavash Iravani. (2023) Genetically engineered bacteria: a new frontier in targeted drug delivery. Journal of Materials Chemistry B 11:42, pages 10072-10087.
Crossref
Crossref
Jiahong Li, Shiwen Yu, Xiaohua Pan, Ming Zhang, Zhuwu Lv, Li-Long Pan & Jia Sun. (2021) Recombinant CRAMP-producing Lactococcus lactis attenuates dextran sulfate sodium-induced colitis by colonic colonization and inhibiting p38/NF-κB signaling. Food & Nutrition Research 65.
Crossref
Crossref
Priscila Valera Guerra, Camila Mattos Andrade, Ivanéia Valeriano Nunes, Brena Cardoso Gama, Rafael Tibúrcio, Washington Luis Conrado Santos, Vasco Ariston Azevedo, Natalia Machado Tavares, Juliana de Souza Rebouças, Tatiani Uceli Maiolii, Ana Maria Caetano Faria & Cláudia Ida Brodskyn. (2021) Oral Tolerance Induced by Heat Shock Protein 65-Producing Lactococcus lactis Mitigates Inflammation in Leishmania braziliensis Infection. Frontiers in Immunology 12.
Crossref
Crossref
Atefeh Afchangi, Tayebeh Latifi, Somayeh Jalilvand, Sayed Mahdi Marashi & Zabihollah Shoja. (2021) Combined use of lactic-acid-producing bacteria as probiotics and rotavirus vaccine candidates expressing virus-specific proteins. Archives of Virology 166:4, pages 995-1006.
Crossref
Crossref
Sagi Sreerohini, Konduru Balakrishna & Manmohan Parida. (2019)
Oral immunization of mice with
Lactococcus lactis
expressing Shiga toxin truncate confers enhanced protection against Shiga toxins of
Escherichia coli
O157:H7 and
Shigella dysenteriae
. APMIS 127:10, pages 671-680.
Crossref
Crossref
Habibah Faroque, Yi Siang Lau, Chee Xian Yong, Raha Abdul Rahim, Suet Lin Chia & Sarah Othman. (2018) Bactofection of SW620 cell by Lactococcus lactis M4. Asia Pacific Journal of Molecular Biology and Biotechnology, pages 29-41.
Crossref
Crossref
N. Zhang, K. Van Crombruggen, E. Gevaert & C. Bachert. (2016) Barrier function of the nasal mucosa in health and type-2 biased airway diseases. Allergy 71:3, pages 295-307.
Crossref
Crossref
Yaron Ilan. (2016) Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease. Clinical & Translational Immunology 5:1, pages e60.
Crossref
Crossref
Romain Hardet, Benjamin Chevalier, Léa Dupaty, Yassine Naïmi, Gaëtan Riou, Laurent Drouot, Laetitia Jean, Anna Salvetti, Olivier Boyer & Sahil Adriouch. (2016) Oral-tolerization Prevents Immune Responses and Improves Transgene Persistence Following Gene Transfer Mediated by Adeno-associated Viral Vector. Molecular Therapy 24:1, pages 87-95.
Crossref
Crossref
Olivia Cano-Garrido, Joaquin Seras-Franzoso & Elena Garcia-Fruitós. (2015) Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes. Microbial Cell Factories 14:1.
Crossref
Crossref
Yi-Fan Hong, Min Seok Ham, Woo Jung Park, Hangeun Kim & Dae Kyun Chung. (2015) Construction of human granulocyte-macrophage colonystimulating factor expression system using Lactococcus lactis MG1363. Food Science and Biotechnology 24:6, pages 2145-2149.
Crossref
Crossref
Sofie Robert, Conny Gysemans, Tatiana Takiishi, Hannelie Korf, Isabella Spagnuolo, Guido Sebastiani, Karolien Van Huynegem, Lothar Steidler, Silvia Caluwaerts, Pieter Demetter, Clive H. Wasserfall, Mark A. Atkinson, Francesco Dotta, Pieter Rottiers, Tom L. Van Belle & Chantal Mathieu. (2014)
Oral Delivery of Glutamic Acid Decarboxylase (GAD)-65 and IL10 by
Lactococcus lactis
Reverses Diabetes in Recent-Onset NOD Mice
. Diabetes 63:8, pages 2876-2887.
Crossref
Crossref
R. Ashraf, T. Vasiljevic, S.C. Smith & O.N. Donkor. (2014) Effect of cell-surface components and metabolites of lactic acid bacteria and probiotic organisms on cytokine production and induction of CD25 expression in human peripheral mononuclear cells. Journal of Dairy Science 97:5, pages 2542-2558.
Crossref
Crossref
Tomás García-Cayuela, Luz P. Gómez de Cadiñanos, M. Luz Mohedano, Pilar Fernández de Palencia, Daniel Boden, Jerry Wells, Carmen Peláez, Paloma López & Teresa Requena. (2012) Fluorescent protein vectors for promoter analysis in lactic acid bacteria and Escherichia coli. Applied Microbiology and Biotechnology 96:1, pages 171-181.
Crossref
Crossref
Tatiana Takiishi, Hannelie Korf, Tom L. Van Belle, Sofie Robert, Fabio A. Grieco, Silvia Caluwaerts, Letizia Galleri, Isabella Spagnuolo, Lothar Steidler, Karolien Van Huynegem, Pieter Demetter, Clive Wasserfall, Mark A. Atkinson, Francesco Dotta, Pieter Rottiers, Conny Gysemans & Chantal Mathieu. (2012) Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice. Journal of Clinical Investigation 122:5, pages 1717-1725.
Crossref
Crossref
Felix Hugentobler, Karen K. Yam, Joshua Gillard, Raya Mahbuba, Martin Olivier & Benoit Cousineau. (2012) Immunization against Leishmania major Infection Using LACK- and IL-12-Expressing Lactococcus lactis Induces Delay in Footpad Swelling. PLoS ONE 7:2, pages e30945.
Crossref
Crossref
P. Mancha Agresti, A. Gala-García, J.G. LeBlanc, A. de Moreno de LeBlanc, V. Azevedo & A. Miyoshi. (2012) Uso potencial de bacterias lácticas como vehículos vacunales. Vacunas 13:1, pages 15-20.
Crossref
Crossref
Daniela Santos Pontes, Marcela Santiago Pacheco de Azevedo, Jean-Marc Chatel, Philippe Langella, Vasco Azevedo & Anderson Miyoshi. (2011) Lactococcus lactis as a live vector: Heterologous protein production and DNA delivery systems. Protein Expression and Purification 79:2, pages 165-175.
Crossref
Crossref
Jesús Rodríguez-Díaz, Rebeca Montava, Rosa Viana, Javier Buesa, Gaspar Pérez-Martínez & Vicente Monedero. (2011) Oral immunization of mice with Lactococcus lactis expressing the rotavirus VP8* protein. Biotechnology Letters 33:6, pages 1169-1175.
Crossref
Crossref
Shen-Shih Chiang, Chin-Feng Liu, Ting-Wei Ku, Jeng-Leun Mau, Hsin-Tang Lin & Tzu-Ming Pan. (2011) Use of Murine Models To Detect the Allergenicity of Genetically Modified Lactococcus lactis NZ9000/pNZPNK. Journal of Agricultural and Food Chemistry 59:8, pages 3876-3883.
Crossref
Crossref
Jerry Wells. (2011) Mucosal Vaccination and Therapy with Genetically Modified Lactic Acid Bacteria. Annual Review of Food Science and Technology 2:1, pages 423-445.
Crossref
Crossref
Harald Renz, Erika von Mutius, Per Brandtzaeg, William O Cookson, Ingo B Autenrieth & Dirk Haller. (2011) Gene-environment interactions in chronic inflammatory disease. Nature Immunology 12:4, pages 273-277.
Crossref
Crossref
Silvia Caluwaerts, Klaas Vandenbroucke, Lothar Steidler, Sabine Neirynck, Peter Vanhoenacker, Sam Corveleyn, Brynmor Watkins, Stephen Sonis, Bernard Coulie & Pieter Rottiers. (2010) AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis. Oral Oncology 46:7, pages 564-570.
Crossref
Crossref